Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

Mckesson KPI & segment coverage

Operating KPI and segment definitions available for Mckesson (MCK) through the VizualStocks API.

MCK8 metric seriesCatalog checked 2026-10-28
Metric catalog API reference Open in the interactive demo

Active metrics 8

SEGMENT

Medical Surgical Solutions Adjusted Segment Operating Profit

Non-GAAP operating profit from McKesson's U.S. medical-surgical distribution and logistics business serving non-acute care providers. McKesson adjusts GAAP segment profit for items including separation-related transaction costs, acquisition-intangible amortization, restructuring and impairment charges, and other specified adjustments.

medicalSurgicalSolutionsAdjustedSegmentOperatingProfit
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

Medical Surgical Solutions Revenue

Revenue from distributing medical-surgical supplies, laboratory equipment and pharmaceuticals to U.S. non-acute care settings such as physician offices, surgery centers, labs, nursing homes, hospice and home health providers. McKesson retains control and consolidates this business while preparing it for separation as an independent company.

medicalSurgicalSolutionsRevenue
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

North American Pharmaceutical Adjusted Segment Operating Profit

Non-GAAP operating profit from McKesson's North American drug-distribution and pharmacy-solutions segment. McKesson adjusts GAAP segment profit for items including acquisition-intangible amortization, transaction costs, LIFO effects, antitrust gains, restructuring and impairment charges, and other specified adjustments.

northAmericanPharmaceuticalAdjustedSegmentOperatingProfit
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

North American Pharmaceutical Revenue

Revenue from McKesson's distribution and logistics of branded, generic, specialty, biosimilar and over-the-counter drugs and other healthcare products in the United States and Canada. The segment also provides operational, financial, clinical and technology services to retail, hospital and alternate-site pharmacies.

northAmericanPharmaceuticalRevenue
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

Oncology Multispecialty Adjusted Segment Operating Profit

Non-GAAP operating profit from McKesson's oncology and specialty-care distribution, provider-services, research and technology businesses. McKesson adjusts GAAP segment profit for acquisition-intangible amortization, transaction costs, LIFO effects, antitrust gains, restructuring and impairment charges, and other specified items.

oncologyMultispecialtyAdjustedSegmentOperatingProfit
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

Oncology Multispecialty Revenue

Revenue from McKesson's oncology and specialty-care platform, including specialty drug and vaccine distribution, group purchasing, infusion and direct-to-patient pharmacy services, and cell and gene therapy support. The segment also includes The U.S. Oncology Network, PRISM Vision, Ontada and Sarah Cannon Research Institute.

oncologyMultispecialtyRevenue
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

Prescription Technology Solutions Adjusted Segment Operating Profit

Non-GAAP operating profit from McKesson's medication-access technology, patient-support and biopharma logistics businesses. McKesson adjusts GAAP segment profit for acquisition-intangible amortization, transaction costs, LIFO effects, antitrust gains, restructuring and impairment charges, and other specified items.

prescriptionTechnologySolutionsAdjustedSegmentOperatingProfit
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint
SEGMENT

Prescription Technology Solutions Revenue

Revenue from technology and logistics that help patients access and afford medicines, including electronic prior authorization, prescription price transparency, benefit insight, dispensing support and patient enrollment. The segment also provides third-party logistics and wholesale distribution support to biopharma companies across the product lifecycle.

prescriptionTechnologySolutionsRevenue
Frequency
quarterly / annual
Reported history
Q2'25 — Q2'26
History endpoint